Joint Global Health Trials (JGHT) Call 11 – outline stage (UKRI Medical Research Council)
Deadline: 8 October 2020
The purpose of this scheme is to provide funding for the best proposals to generate new knowledge about interventions that will contribute to the improvement of health in low and middle income countries (LMICs). The scheme is focused on late-stage clinical and health intervention trials evaluating efficacy and effectiveness.
Call 11 specifically invites applications for definitive randomised controlled trials (RCTs) that provide generalisable data, beyond a single country or setting. The evidence generated should be robust and relevant to international and regional policy makers and directly answer questions to change policy and guidance.
This scheme is open to Principal Investigators who are employed by eligible research institutions based in LMICs where the work will take place and to Principal Investigators who are employed by an eligible UK institution.
Although the breadth of the scheme is deliberately wide, they particularly welcome proposals for research addressing the coexistence of two or more chronic conditions in the same individual as well as more broadly addressing chronic non- communicable diseases, including mental health, reproductive, maternal and new born health.
The scheme encourages the evaluation of a wide range of intervention types including, but not limited to:
- behavioural interventions
- psychological therapies
- disease management
- hygiene interventions
- diagnostic strategies
A total of up to £20 million is available for this call from the UK Department for International Development (DFID), the UK Medical Research Council (MRC), the National Institute for Health Research (NIHR) and Wellcome. The funders welcome trial proposals costed appropriately to provide definitive results. Around £1 million of the total budget is expected to be spent on several trial development grants.
Deadline: 8 October 2020, 16:00 GMT+1 (10:00 Colombian time)
[Boletín SIUN 494, 9 de julio de 2020]